|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Studies on anti meta- static and anti invasive effects of harmine using highly metastatic routine bl6f-10 melanoma eells显示文摘 | Hamsa TP Kuttan G Centre ACR | 2011 | J Environ Pathol Toxicol On- col2011，30，2： | 1 |
| 2 | A study of cements formed by aqueous lactic acid and aluminosilicate glass显示文摘 | John W. Nicholson Hamsa Tawfik Beata Czarnecka | 2002 | Journal of Materials Science: Materials in Medicine2002，，4： | 1 |
| 3 | Evaluation of the anti-inflammatory and antitumor effect of ipomoea ohscura (L) and its mode of action through the inhibition of pro inflammatory cytokines, nitric oxide and COX2显示文摘 | Hamsa TP Kuttan G | 2011 | Inflammation2011，34，3： | 1 |
| 4 | Chemical composition of the swimming crab Portunus pelagicus Linnaeus显示文摘 | Hamsa K | 1978 | Indian Journal of Fisheries1978，25，12： | 1 |
| 5 | The Proapoptotic Activity of the Bcl-2 Family Member Bim Is Regulated by Interaction with the Dynein Motor Complex显示文摘 | Hamsa Puthalakath David C.S Huang Lorraine A O’Reilly Stephen M King Andreas Strasser | 1999 | Molecular Cell1999，，3： | 1 |
| 6 | Effect of Thuja oecidentalis and its polysaccharide on cell- mediated immune responses and cytokine levels of metastatic tumor-bearing animals 显示文摘 | Sunila E S Hamsa T P Kuttan G | 2011 | Pharmaceutical biology2011，49，10： | 1 |
| 7 | Formulation and evaluation of transderrnal films of terbutaline sulphate 显示文摘 | Murthy SN Hamsa V Bhaskaran S | 1997 | Indian J Pharm Sci1997，57，5： | 1 |
| 8 | Systematic Implementation of Innovation Best Practices:Thota Framework for Innovation显示文摘The Product Development and Management Association(PDMA)comparative performance assessment studies(CPAS)teach us that the new product development(NPD)and innovation management practices continue to evolve.However,advances in the practice of NPD and innovation did not yield significant increases in new product success rates.However,the PDMA 2003 CPAS reported a significant difference in the success rates for top performing businesses versus the'rest'.This paper summarizes innovation practices of top performing businesses from CPAS and compares them with the practices of PDMA Outstanding Corporate Innovator(OCI)Award winning companies.The paper verifies that what the top performers say they do in research surveys is actually what the outstanding corporate innovators do in practice.The paper then raises the question of how underperforming companies can implement key learnings from the best to improve their own innovation performance.The development of Thota framework for innovation as a systematic framework to help underperformers implement the best practices is discussed.As a case study,the implementation of the Thota framework for innovation is illustrated with BMW,an OCI award winning company.The Thota Framework for Innovation is based on three organizing principles and eight actions.Underperforming businesses can improve their innovation performance by internalizing the three organizing principles and rigorously implementing eight actions specified in the Thota framework for innovation. | Hamsa Thota | 2011 | 创新与创业管理2011，，1： | 1 |
| 9 | Harmine activates intrinsic and extrinsic path- ways of apoptosis in B16F-10 melanoma 显示文摘 | Hamsa T P Kuttan G | 2011 | Chin Med2011，6，1： | 1 |
| 10 | Harmine inhibits tumour specific neo-vessel formation by regulating VEGF,MMP,TIMP and pro-in-flammatory mediators both in vivo and in vitro显示文摘 | HAMSA T P KUTTAN G | 2010 | Eur J Pharma-col2010，649，13： | 1 |
| 11 | Harmine inhibits tumour specific neo-vessel for-mation by regulating VEGF, MMP,TIMP and pro-inflammatory medi- ators both in vivo and in vitro显示文摘 | Hamsa TP Kuttan G | 2010 | Eur J Pharmacol2010，649，13： | 1 |
| 12 | Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-in- ducible factor-l,VEGF,and proinflamma to ry mediators 显示文摘 | Hamsa TP Kuttan G | 2012 | Drug Chem Toxicol2012，35，1： | 1 |
| 13 | Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B 16F-10 melanoma cells显示文摘 | Hamsa TP Kuttan G | 2012 | Phytother Res2012，26，4： | 1 |
| 14 | Antiangiogenic activity of herherine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators 显示文摘 | Hamsa T P Kuttan G | 2012 | Drug Chem Toxicol2012，35，1： | 1 |
| 15 | Kodak Digital Camera and The Lost Business Opportunity显示文摘A systematic study of Kodak’s annual operations and business strategies during 2000-2010revealed that Kodak management faltered in transitioning the Kodak Company from an analog business model to a digital business model.In 2000 Kodak delivered strong performance and it appeared to be smart to be in the picture business.In 2002Kodak was the best-performing stock among companies that made up the Dow Jones Industrial Average.In 2005Kodak future looked bright.A confident Chairman and CEO Antonio M.Perez pronounced that by 2008he expected all of Kodak’s businesses to be leaders in their industry segments.In 2008Kodak remained as the most recognized and respected brands in the world but it played in the hyper competitive markets in which price and technological advances drove the market.So Kodak was unable to reap premium prices from its famous brand and it became a nonviable business due to sustained losses from continuing operations.During 2008-2012 Kodak fell from being a market leader to becoming a bankrupt Company.Using the analogy of'behind the power curve',this article shines light on Kodak’s crash to the ground,i.e.bankruptcy filing in 2012and asserts that Kodak management triggered the process of falling behind the power curve in 2000when it embraced the infoimaging strategy to extend the benefits of film.Kodak’s 2003digital business model and other strategies that followed it did not allow Kodak to become a strong competitor in the digital world.Kodak digital camera business became a lost business opportunity. | Hamsa Thota | 2012 | 创新与创业管理2012，，1： | 1 |
| 16 | PPARdeha promotes wound healing by upregulating TGF-betal-dependent orindependent expression of extracellular matrix proteins 显示文摘 | HamSA Kim H J KangE S | 2009 | J Cell Mol Med2009，，： | 1 |
| 17 | Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro显示文摘 | T.P. Hamsa Girija Kuttan | 2010 | European Journal of Pharmacology2010，，1： | 1 |
| 18 | Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-in-ilammatory mediators both in vivo and in vitro 显示文摘 | HAMSA TP KUTTAN G | 2010 | Eur J Phar-macol2010，649，13： | 1 |
| 19 | Harmine activates intrinsic and extrin-sic pathways of apoptosis in B16F-10 melanoma显示文摘 | HAMSA TP KUTTAN G | 2011 | Chin Med2011，6，1： | 1 |
| 20 | Induction of apoptosis by fulforaphane in highly metastatic B16F-10 melanoma cells 显示文摘 | Hamsa TP Thejass P Kuttan G | 2011 | Drug Chem Toxicol2011，34，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员